CAS 2092925-89-6

(1R,3R)-2-(2-Fluoro-2-methylpropyl)-2,3,4,9-tetrahydro-3-methyl-1-[4-[(1-propyl-3-azetidinyl)oxy]phenyl]-1H-pyrido[3,4-b]indole

CAS: 2092925-89-6

Pureza: 99%

Ref: IN-DA02AP3U

Palazestrant

CAS: 2092925-89-6

Palazestrant

Fórmula: C₂₈H₃₆FN₃O

Pureza: ≥95%

Peso molecular: 449.6

Ref: 54-BUP01207

Palazestrant

CAS: 2092925-89-6

(1R,3R)-2-(2-Fluoro-2-methylpropyl)-3-methyl-1-(4-((1-propylazetidin-3-yl)oxy)phenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole

Fórmula: C₂₈H₃₆FN₃O

Pureza: 99%

Peso molecular: 449.6

Ref: IN-DG01829190

Palazestrant

CAS: 2092925-89-6

Palazestrant, an antiestrogen and antineoplastic agent, effectively targets ER+/HER2+ cancer when used in conjunction with a HER2 inhibitor.

Fórmula: C₂₈H₃₆FN₃O

Pureza: 97.55%

Forma y color: Solid

Peso molecular: 449.6

Ref: TM-T72945